Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Research

Molecular epidemiology and phylodynamic analysis of enterovirus 71 in Beijing, China, 2009–2019

Authors: Jie Li, Zhichao Liang, Da Huo, Yang Yang, Renqing Li, Lei Jia, Xiaoli Wang, Chun Huang, Quanyi Wang

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Background

Enterovirus 71(EV71)-associated hand, foot and mouth disease (HFMD) decreased dramatically in Beijing from 2009 to 2019. This study was to investigate the epidemiological characteristics, evolutionary dynamics, geographic diffusion pathway, and other features of EV71 in Beijing, China.

Methods

We conducted a retrospective study of EV71-associated HFMD and its causative agent in Beijing, China, from 2009 to 2019. Phylogenetic and phylogeographic methods based on the EV71 genome were used to determine the evolution features, origin, and spatiotemporal dynamics. Positive selection sites in the VP1 gene were identified and exhibited in the tertiary structure. Bayesian birth-death skyline model was used to estimate the effective reproductive number (Re).

Results

EV71-associated HFMD decreased greatly in Beijing. From 2009 to 2019, EV71 strains prevalent in Beijing shared high homology in each gene segment and evolved with a rate of 4.99*10− 3 substitutions per site per year. The genetic diversity of EV71 first increased and peaked in 2012 and then decreased with fluctuations. The time to the most recent common ancestor (TMRCA) of EV71 in Beijing was estimated around 2003 when the EV71 strains were transmitted to Beijing from east China. Beijing played a crucial role in seeding EV71 to central China as well. Two residues (E145Q/G, A293S) under positive selection were detected from both the VP1 dataset and the P1 dataset. They were embedded within the loop of the VP1 capsid and were exposed externally. Mean Re estimate of EV71 in Beijing was about 1.007.

Conclusion

In recent years, EV71 was not the primary causative agent of HFMD in Beijing. The low Re estimate of EV71 in Beijing implied that strategies for preventing and controlling HFMD were performed effectively. Beijing and east China played a crucial role in disseminating EV71 to other regions in China.
Appendix
Available only for authorised users
Literature
15.
go back to reference Joe Parker. BaTS – Bayesian Tip-association Significance testing. Version 2 Documentation. Joe Parker. BaTS – Bayesian Tip-association Significance testing. Version 2 Documentation.
24.
25.
go back to reference Zeng F, Shi Y, Liu J, YU S, Wei Z. Characteristics analysis of VP1 gene of EV71 isolated from hand-foot-muth disease in Huai’nan during 2014–2015. Chin J Health Lab Tec. 2018;28(7):1–3. Zeng F, Shi Y, Liu J, YU S, Wei Z. Characteristics analysis of VP1 gene of EV71 isolated from hand-foot-muth disease in Huai’nan during 2014–2015. Chin J Health Lab Tec. 2018;28(7):1–3.
Metadata
Title
Molecular epidemiology and phylodynamic analysis of enterovirus 71 in Beijing, China, 2009–2019
Authors
Jie Li
Zhichao Liang
Da Huo
Yang Yang
Renqing Li
Lei Jia
Xiaoli Wang
Chun Huang
Quanyi Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02028-9

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.